Skip to content
Recall Observatory FDA recall evidence

Drug product

Tiagabine Hydrochloride Tablets, 2 mg, 30-count bottle, Distributed by Sun Pharmaceutical Industries. Inc. Cranbury NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gujarat, India. NDC#: 62756-200-83

D-0914-2023

July 10, 2023

Class II

Product summary

Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Event
Event 92671
Status
Terminated
Classification
Class II
Quantity
8,880 30-count bottles
Official record key
drug-enforcement:D-0914-2023

Official wording

Reason: Failed Impurities: Out of Specification (OOS) result observed during Related Substances testing

Code information: Lot HAC3339A, Expires 07/2023

Distribution pattern: Distributed nationwide in the USA.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of Specification